Clinical Trials

Inclusion Criteria:

• Able and willing to participate and provide consent.
• Age ≥ 18 years.
• Male or female.
• Immunocompetent or Immunosuppressed.
• Respiratory infection may be either CAP or Valley Fever:
  • CAP as diagnosed by medical provider in conjunction with all  the following:
    • Presence of typical symptoms;
    • Presence of supporting diagnostic imaging;
    • Presence of supporting diagnostic testing.
  • Proven or probable primary pulmonary coccidioidomycosis (VF):
    • Presence of typical symptoms;
    • Presence of typical radiographic abnormalities;
    • Probable: requires positive serology initially or in follow up (NOT EIA IgM-only seropositivity);
    • Proven: requires positive culture, cytology, PCR or pathologic results.
• Inpatient or outpatient at enrollment.

Exclusion Criteria: 

• Unable or unwilling to participate or provide consent.
• Age < 18 years.
• History of lung transplant.
• Systemic antifungal  treatment  of >1 week duration within past 30 days.
• Diagnosed or treated currently with any of the following:
  • Pneumonia from 2 or more concurrent microbiologic etiologies;
  • Oral candidiasis.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 11/27/23. Questions regarding updates should be directed to the study team contact.